Creatine prevents the imbalance of redox homeostasis caused by homocysteine in skeletal muscle of rats

Gene

Volumn 545, Issue 1, 2014, Pages 72-79

  Kolling, Janaína ^a   Scherer, Emilene B S ^a   Siebert, Cassiana ^a   Marques, Eduardo Peil ^a   dos Santos, Tiago Marcom ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Creatine; Oxidative stress; Severe hyperhomocysteinemia; Soleus skeletal muscle

Indexed keywords

ANTIOXIDANT; CARBONYL DERIVATIVE; CATALASE; CREATINE; DICHLOROFLUORESCEIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; NITRITE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOL DERIVATIVE; 2',7'-DICHLOROFLUORESCEIN; FLUORESCEIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; HYPERHOMOCYSTEINEMIA; LIPID PEROXIDATION; MALE; MUSCLE FUNCTION; MUSCLE INJURY; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SOLEUS MUSCLE; ANIMAL; DRUG EFFECTS; HOMEOSTASIS; METABOLISM; OXIDATION REDUCTION REACTION; SKELETAL MUSCLE; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; CATALASE; CREATINE; FEMALE; FLUORESCEINS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMEOSTASIS; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; MALE; MUSCLE, SKELETAL; NITRITES; OXIDATION-REDUCTION; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84901236835     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.05.005     Document Type: Article

References (80)

1. Aebi H. Catalase in vitro. Methods in Enzymology 1984, 105:121-126.
2. Aksenov M.Y., Markesbery W.R. Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neuroscience Letters 2001, 302:141-145.
3. Balestrino M., Lensman M., Parodi M., Perasso L., Rebaudo R., Melani R., Polenov S., Cupello A. Role of creatine and phosphocreatine in neuronal protection from anoxic and ischemic damage. Amino Acids 2002, 23:221-229.
4. Beal F.M. Neuroprotective effects of creatine. Amino Acids 2011, 40:1305-1313.
5. Bender A., Koch W., Elstner M., Schombacher Y., Bender J., Moeschl M., Gekeler F., Müller-Myhsok B., Gasser T., Tatsch K., Klopstock T. Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial. Neurology 2006, 67:1262-1264.
6. Blundell G., Jones B.G., Rose F.A., Tudball N. Homocysteine mediated endothelial cell toxicity and its amelioration. Atherosclerosis 1996, 122:163-172.
7. Browne R.W., Armstrong D. Reduced glutathione and glutathione disulfide. Methods in Molecular Biology 1998, 108:347-352.
8. Caretti A., Bianciardi P., Sala G., Terruzzi C., Lucchina F., Samaja M. Supplementation of creatine and ribose prevents apoptosis in ischemic cardiomyocytes. Cellular Physiology and Biochemistry 2010, 26:831-838.
9. Carocho M., Ferreira I.C. A review on antioxidants, prooxidants and related controversy: natural and synthetic compounds, screening and analysis methodologies and future perspectives. Food and Chemical Toxicology 2013, 51:15-25.
10. Chen N.C., Yang F., Capecci L.M., Gu Z., Schafer A.I., Durante W., Yang X.F., Wang H. Regulation of homocysteine metabolism and methylation in human and mouse tissues. The FASEB Journal 2010, 24:2804-2817.
11. Chung Y.L., Alexanderson H., Pipitone N., Morrison C., Dastmalchi M., Stahl-Hallengren C., Richards S., Thomas E.L., Hamilton G., Bell J.D., Lundberg I.E., Scott D.L. Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: 6-month, double-blind, randomized, placebo-controlled trial. Arthritis and Rheumatism 2007, 57:694-702.
12. Craft S., Foster T.C., Landfield P.W., Maier S.F., Resnick S.M., Yaffe K. Session III: mechanisms of age-related cognitive change and targets for intervention: inflammatory, oxidative, and metabolic processes. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2012, 67:754-759.
13. Dalle-Donne I., Rossi R., Giustarini D., Milzani A., Colombo R. Protein carbonyl groups as biomarkers of oxidative stress. Clinica Chimica Acta 2003, 329:23-38.
14. Davenpeck K.L., Gauthier T.W., Lefer A.M. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994, 107:1050-1058.
15. Dayal S., Arning E., Bottiglieri T., Böger R.H., Sigmund C.D., Faraci F.M., Lentz S.R. Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 2004, 8:1957-1962.
16. Deminice R., Jordao A.A. Creatine supplementation reduces oxidative stress biomarkers after acute exercise in rats. Amino Acids 2012, 43:709-715.
17. Deminice R., Vilhena R., Portari G.V., Jordão A.A. Suplementação de creatina, homocisteína e estresse oxidativo. Medicina 2007, 40:368-377.
18. Ekelund U.E., Harrison R.W., Shokek O., Thakkar R.N., Tunin R.S., Senzaki H., Kass D.A., Marbán E., Hare J.M. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circulation Research 1999, 85:437-445.
19. Faraci F.M., Lentz S.R. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004, 35:345-347.
20. Gamble P.E., Burke J.J. Effect of water stress on the chloroplast antioxidant system: I. Alterations in glutathione reductase activity. Plant Physiology 1984, 76:615-621.
21. Gielen S., Schuler G., Adams V. Cardiovascular effects of exercise training. Circulation 2010, 122:1221-1238.
22. Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Analytical Biochemistry 1982, 126:131-138.
23. Gualano B., Painelli V.S., Roschel H., Lugaresi R., Dorea E., Artioli G.G., Lima F.R., da Silva M.E., Cunha M.R., Seguro A.C., Shimizu M.H., Otaduy M.C., Sapienza M.T., Leite C.C., Bonfá E., Junior A.H.L. Creatine supplementation does not impair kidney function in type 2 diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. European Journal of Applied Physiology 2011, 111:749-756.
24. Halliwell B. Free radicals and antioxidants - quo vadis?. Trends in Pharmacological Sciences 2011, 32:125-130.
25. Hammouda O., Chtourou H., Chaouachi A., Chahed H., Ferchichi S., Kallel C., Chamari K., Souissi N. Effect of short-term maximal exercise on biochemical markers of muscle damage, total antioxidant status, and homocysteine levels in football players. Asian Journal of Sports Medicine 2012, 3:239-246.
26. Hogg R.S., Bangsberg D.R., Lima V.D., Alexander C., Bonner S., Yip B., Wood E., Dong W.W., Montaner J.S., Harrigan P.R. Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART. PLoS Medicine 2006, 3:e356.
27. Huang R.F., Hsu Y.C., Lin H.L., Yang F.L. Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers. The Journal of Nutrition 2001, 131:33-38.
28. Huang C.R., Chang W.N., Tsai N.W., Lu C.H. Serial nerve conduction studies in vitamin B12 deficiency-associated polyneuropathy. Neurological Sciences 2011, 32:183-186.
29. Ishii I., Akahoshi N., Yamada H., Nakano S., Izumi T., Suematsu M. Cystathionine gamma-Lyase-deficient mice require dietary cysteine to protect against acute lethal myopathy and oxidative injury. The Journal of Biological Chemistry 2010, 285:26358-26368.
30. Kolling J., Wyse A.T. Creatine prevents the inhibition of energy metabolism and lipid peroxidation in rats subjected to GAA administration. Metabolic Brain Disease 2010, 25:331-338.
31. Kolling J., Scherer E.B., da Cunha A.A., da Cunha M.J., Wyse A.T. Homocysteine induces oxidative-nitrative stress in heart of rats: prevention by folic acid. Cardiovasc Toxicol 2011, 11:67-73.
32. Kolling J., Scherer E.B., Siebert C., Hansen F., Torres F.V., Scaini G., Ferreira G., de Andrade R.B., Gonçalves C.A., Streck E.L., Wannmacher C.M., Wyse A.T. Homocysteine induces energy imbalance in rat skeletal muscle: is creatine a protector?. Cell Biochemistry and Function 2013, 31:575-584.
33. Lang D.R., Davis J.A., Lopes L.G., Ferro A.A., Vasconcellos L.C., Franco D.W., Tfouni E., Wieraszko A., Clarke M.J. A controlled NO-releasing compound: synthesis, molecular structure, spectroscopy, electrochemistry, and chemical reactivity of R, R, S, S-trans-[RuCl(NO)(cyclam)]2+(1,4,8,11-tetraazacyclotetradecane). Inorganic Chemistry 2000, 39:2294-2300.
34. Lawler J.M., Barnes W.S., Wu G., Song W., Demaree S. Direct antioxidant properties of creatine. Biochemical and Biophysical Research Communications 2002, 290:47-52.
35. LeBel C.P., Ischiropoulos H., Bondy S.C. Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chemical Research in Toxicology 1992, 5:227-231.
36. Leishear K., Ferrucci L., Lauretani F., Boudreau R.M., Studenski S.A., Rosano C., Abbate R., Gori A.M., Corsi A.M., Di Iorio A., Guralnik J.M., Bandinelli S., Newman A.B., Strotmeyer E.S. Vitamin B12 and homocysteine levels and 6-year change in peripheral nerve function and neurological signs. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences 2012, 67:537-543.
37. Liu S.Q., Fung Y.C. Changes in the organization of the smooth muscle cells in rat vein grafts. Annals of Biomedical Engineering 1998, 26:86-95.
38. Lobo V., Patil A., Phatak A., Chandra N. Free radicals, antioxidants and functional foods: impact on human health. Pharmacognosy Reviews 2010, 4:118-126.
39. Lowry O.H., Rosebrough N.J., Farr A.L., RandalL R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry 1951, 193:265-267.
40. MacCarthy P.A., Grieve D.J., Li J.M., Dunster C., Kelly F.J., Shah A.M. Impaired endothelial regulation of ventricular relaxation in cardiac hypertrophy: role of reactive oxygen species and NADPH oxidase. Circulation 2001, 104:2967-2974.
41. Majors A.K., Sengupta S., Jacobsen D.W., Pyeritz R.E. Upregulation of smooth muscle cell collagen production by homocysteine-insight into the pathogenesis of homocystinuria. Molecular Genetics and Metabolism 2002, 76:92-99.
42. Marí M., Morales A., Colell A., García-Ruiz C., Fernández-Checa J.C. Mitochondrial glutathione, a key survival antioxidant. Antioxidants and Redox Signaling 2009, 11:2685-2700.
43. Marklund S.L. Pyrogallol autoxidation. Handbook for Oxygen Radical Research 1985, 243-247. CRC Press, Boca Raton.
44. Martensson J., Meister A. Mitochondrial damage in muscle occurs after marked depletion of glutathione and is prevented by giving glutathione monoester. Proceedings of the National Academy of Sciences of the United States of America 1989, 86:471-475.
45. Matté C., Stefanello F.M., Mackedanz V., Pederzolli C.D., Lamers M.L., Dutra-Filho C.S., Dos Santos M.F., Wyse A.T. Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats. International Journal of Developmental Neuroscience 2009, 27:337-344.
46. McCully K.S. Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases. Annals of Clinical and Laboratory Science 2011, 41:301-314.
47. Mudd S.H., Poole J.R. Labile methyl balances for normal humans on various dietary regimens. Metabolism 1975, 24:721-735.
48. Mudd S.H., Levy H.L., Skovby F. Disorders of transsulfuration. The Metabolic and Molecular Basis of Inherited Disease 2001, 1279-1327. McGraw-Hill, New York. C.R. Scriver, A.L. Beaudet, W.S. Sly, D. Valle (Eds.).
49. Mujumdar V.S., Aru G.M., Tyagi S.C. Induction of oxidative stress by homocysteine impairs endothelial function. Journal of Cellular Biochemistry 2001, 82:491-500.
50. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 1979, 95:351-358.
51. Owen L., Sunram-Lea S.I. Metabolic agents that enhance ATP can improve cognitive functioning: a review of the evidence for glucose, oxygen, pyruvate, creatine, and l-carnitine. Nutrients 2011, 3:735-755.
52. Persky A.M., Brazeau G.A. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacological Reviews 2001, 53:161-176.
53. Persky A.M., Brazeau G.A., Hochhaus G. Pharmacokinetics of the dietary supplement creatine. Clinical Pharmacokinetics 2003, 42:557-574.
54. Prudova A., Bauman Z., Braun A., Vitvitsky V., Lu S.C., Banerjee R. S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:6489-6494.
55. Radomski M.W., Palmer R.M., Moncada S. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 1990, 87:10043-10047.
56. Rahman K. Studies on free radicals, antioxidants, and co-factors. Clinical Interventions in Aging 2007, 2:219-236.
57. Ratnam D.V., Ankola D.D., Bhardwaj V., Sahana D.K., Kumar M.N. Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. Journal of Controlled Release 2006, 113:189-207.
58. Sestili P., Martinelli C., Colombo E., Barbieri E., Potenza L., Sartini S., Fimognari C. Creatine as an antioxidant. Amino Acids 2011, 40:1385-1396.
59. Snow R.J., Murphy R.M. Factors influencing creatine loading into human skeletal muscle. Exercise and Sport Sciences Reviews 2003, 31:154-158.
60. Stadtman E.R., Levine R.L. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 2003, 25:207-218.
61. Stead L.M., Au K.P., Jacobs R.L., Brosnan M.E., Brosnan J.T. Methylation demand and homocysteine metabolism: effects of dietary provision of creatine and guanidinoacetate. American Journal of Physiology. Endocrinology and Metabolism 2001, 281:1095-1100.
62. Steed M.M., Tyagi S.C. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxidants and Redox Signaling 2011, 15:1927-1943.
63. Streck E.L., Matte C., Vieira P.S., Rombaldi S., Wannmacher C.M., Wajner M., Wyse A.T. Reduction of Na(+), K(+)-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia. Neurochemical Research 2002, 27:1593-1598.
64. Streck E.L., Delwing D., Tagliari B., Matté C., Wannmacher C.M., Wajner M., Wyse A.T. Brain energy metabolism is compromised by the metabolites accumulating in homocystinuria. Neurochemistry International 2003, 43:597-602.
65. Swart K.M., van Schoor N.M., Blom H.J., Smulders Y.M., Lips P. Homocysteine and the risk of nursing home admission and mortality in older persons. European Journal of Clinical Nutrition 2012, 66:188-195.
66. Taes Y.E., Delanghe J.R., De Vriese A.S., Rombaut R., Van Camp J., Lameire N.H. Creatine supplementation decrease homocysteine in an animal model of uremia. Kidney International 2003, 64:1331-1337.
67. Terjung R.L., Clarkson P., Eichner E.R., Greenhaff P.L., Hespel P.J., Israel R.G., Kraemer W.J., Meyer R.A., Spriet L.L., Tarnopolsky M.A., Wagenmakers A.J., Williams M.H. American college of sports medicine roundtable, the physiological and health effects of oral creatine supplementation. Medicine and Science in Sports and Exercise 2000, 32:706-717.
68. Valentino F., Bivona G., Butera D., Paladino P., Fazzari M., Piccoli T., Ciaccio M., La Bella V. Elevated cerebrospinal fluid and plasma homocysteine levels in ALS. European Journal of Neurology 2010, 17:84-89.
69. Veeranki S., Tyagi S.C. Defective homocysteine metabolism: potential implications for skeletal muscle malfunction. International Journal of Molecular Sciences 2013, 14:15074-15091.
70. Villanueva C., Giulivi C. Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease. Free Radical Biology & Medicine 2010, 49:307-316.
71. Wallimann T., Wyss M., Brdiczka D., Nicolay K. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the phosphocreatine circuit' for cellular energy homeostasis. The Biochemical Journal 1992, 28:121-140.
72. Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Current Drug Metabolism 2005, 6:27-36.
73. Wendel A. Glutathione peroxidase. Methods in Enzymology 1981, 77:325-333.
74. Wiernsperger N.F. Oxidative stress: the special case of diabetes. Biofactors 2003, 19:11-18.
75. Williams K.T., Schalinske K.L. Homocysteine metabolism and its relation to health and disease. Biofactors 2010, 36:19-24.
76. Wyss M., Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiological Reviews 2000, 80:1107-1213.
77. Wyss M., Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?. Neuroscience 2002, 112:243-260.
78. Xu L.B., Wang Z.X., Qi D., Lin X.F., Ying W.G., Sun S.J., Chen B., Ji P. A preliminary study on the effects of the exogenous creatine phosphate on rat masseter muscle after unilateral chew. Hua Xi Kou Qiang Yi Xue Za Zhi 2010, 28:348-351.
79. Zoccolella S., Simone I.L., Lamberti P., Samarelli V., Tortelli R., Serlenga L., Logroscino G. Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis. Neurology 2008, 70:222-225.
80. Zoccolella S., Tortorella C., Iaffaldano P., Direnzo V., D'Onghia M., Paolicelli D., Livrea P., Trojano M. Elevated plasma homocysteine levels in patients with multiple sclerosis are associated with male gender. Journal of Neurology 2012, 259:2105-2110.